| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Immunology, Holland Lab, American Red Cross, Rockville, MD 20855;
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and
Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Previous studies using murine or human T lymphocytes have shown that antioxidants inhibit activation-induced death, suggesting a role for reactive oxygen intermediates (ROI) (9, 10). Furthermore, ROI are generated by TCR signaling and may act in a signal-transduction capacity, selectively affecting TCR-induced expression of FasL on the surface of stimulated cells (9).
The reactive intermediate nitric oxide (NO) has also been shown to function in a signal-transduction capacity, leading to vascular smooth muscle relaxation (11, 12), and functioning as a second messenger in other systems, especially the brain (13, 14). In the immune system, stimulated production of NO from activated macrophages has primarily been proposed to act in a toxic fashion, participating in host defense against tumors or parasitic infections (15, 16). The high levels of NO produced by macrophages, which is generated by the inducible form of NO synthase (iNOS), have been shown to induce an apoptotic cell death in a variety of cells (17, 18), and have also been proposed to alter the responsiveness of both T and B lymphocytes to Ag or mitogen stimulus (19).
Recent evidence suggests that lymphocytes themselves can produce low
levels of NO that can modulate events in the cell. Th1 murine T cell
clones stimulated by mitogen or Ag were shown to produce NO via iNOS,
and NOS inhibitors were able to modulate their cytokine production
(20). In studies on human lymphocytes, Mannick et al. (21) showed low,
constitutive expression of iNOS in EBV-transformed human B lymphocyte
cell lines. Use of NOS inhibitors and NO donors suggested that
endogenous NO production inhibits EBV reactivation and apoptosis in
these cells, although direct evidence of NO generation was not shown.
Another study of human B and T lymphocytes detected expression of
endothelial NOS (eNOS) mRNA in primary cultures and cell lines (22).
Expression of eNOS protein was also described in a 
T cell clone,
and the NO generated by this enzyme was proposed to inhibit
Fas-mediated apoptosis (23). Thus, lymphocytes have been shown to have
the capacity for NO production, and this production may have the
capacity to affect immune responses.
In the current study, models of TCR-triggered or activation-induced apoptotic death of murine T cell hybridomas and activated human T cell blasts were examined for dependence upon NO generation. Inhibitors of NOS stereospecifically protected from TCR triggered cell death and importantly, decreased FasL expression induced by TCR signals. TCR-stimulated NO production was demonstrated by the increased formation of nitrotyrosine, a stable product of NO generation. NOS activity was detected in lysates of T cells and was immunochemically determined to be the neuronal form of NOS (nNOS). Thus, TCR signaling leads to NO production that affects FasL gene expression and apoptotic cell death of T cells.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
FITC anti-human CD69 and anti-human Fas IgG were obtained from PharMingen (San Diego, CA), while anti-human Fas IgM and polyclonal anti-nitrotyrosine were from Upstate Biotechnology (Lake Placid, NY). All anti-NOS Abs were obtained from Transduction Laboratories (Lexington, KY), while all other chemicals were obtained from Sigma (St. Louis, MO).
Cells
The T cell hybridoma, 2B4 (a generous gift from Dr. Charles Zacharcuk, National Institute of Health), and Jurkat human T cells were maintained in RPMI 1640 with 10% heat-inactivated FBS supplemented with antibiotics and 50 µM 2-ME. The 2B4 cells were induced to undergo PCD through culture on immobilized anti-CD3 Ab (2C11) or incubation with the steroid dexamethasone, and in all experiments inhibitors were added simultaneous with anti-CD3 or with steroid.
Human peripheral T cell blasts were prepared from purified T cells (24) from human PBMC by culture for 2 days with 2 µg/ml PHA and 10 U/ml rIL-2, followed by further culture in RPMI 1640 medium with 10% heat-inactivated FBS supplemented with antibiotics, 50 µM 2-ME, and rIL-2 (10 U/ml). These cells are then susceptible to activation-induced apoptotic death via challenge by immobilized anti-CD3 (OKT3).
IL-2 assay
IL-2 released from 2B4 cells upon Ab stimulation was measured in culture supernatants by bioassay, as previously described (9). Supernatants were serially diluted in a 96-well plate, and 5 x 104 CTLL cells were added to each well. After 24-h incubation, 1 µCi [3H]thymidine was added to each well and the cells were incubated for 18 h before harvest on an automated filter harvester. Human rIL-2 (Boehringer Mannheim, Indianapolis, IN) was used as a standard for each assay, and the data were converted to units of IL-2 using this standard curve.
Assay of apoptotic morphology and cell death
Following programmed cell death (PCD) stimulation, cells were harvested and stained in medium with 5 µg/ml Hoechst 33342 (Sigma) for 15 min at 37°C. Propidium iodide (PI) (final concentration 20 µg/ml) was added, the cells pelleted, resuspended in a minimal volume, and examined in a fluorescence microscope. At least 300 cells were counted per sample in at least five random fields, and nuclei scored as red (PI positive) or blue (PI negative), as well as by morphology (diffuse or normal staining versus apoptotic morphology, as seen by condensed chromatin). Percentage of inhibition of death was calculated as: % inhibition = [1 - (%apoptoticAb+drug - %apoptoticdrug)/(%apoptoticAb - %apoptoticuntreated)] x 100, where apoptotic is defined as any cell (PI+ or PI-) that displays nuclear morphology consistent with chromatin condensation.
Functional assays of Fas and FasL
FasL expression was induced following incubation of T cells on immobilized anti-CD3 or with PMA (10 ng/ml) plus ionomycin (1 µg/ml). Incubation was conducted in the presence or absence of inhibitors at the indicated concentrations for 6 h, and the cells were washed, fixed lightly with 0.6% formaldehyde in PBS for 1 min at room temperature, as previously described (9), and washed twice more before being resuspended in complete medium. Fas-bearing target cells (Jurkat) were loaded with 51Cr and incubated overnight at different E:T ratios with the fixed effectors in the absence or presence of inhibitors. The effects of inhibitors were analyzed via calculation of lytic units, which quantitates the amount of effector cells required to achieve a given level of target lysis (25). Comparison of these values then indicates the effect of the inhibitors on FasL surface expression levels or the ability of cells to be killed via Fas signaling. Specificity of lysis was determined through the use of unstimulated effector cells and inhibition of Fas-dependent killing with soluble anti-Fas IgG.
FasL surface expression was determined by flow cytometry essentially as previously described (26). Human T blasts were incubated for 6 h in wells coated with 10 µg/ml anti-CD3 (OKT3) in the presence or absence of NOS inhibitors. Cells were stained with biotin anti-human FasL (NOK-1; PharMingen) or biotinylated isotype control, followed by tetramethylrhodamine isothiocyanate (TRITC)-streptavidin (Southern Biotechnology Associates, Birmingham, AL), and analyzed on the FACScan (Becton Dickinson, Mountain View, CA).
Intracellular staining for nitrotyrosine
Treatment of cells was performed as described above for FasL induction, and after different times cells were harvested, fixed with ice-cold 80% MeOH on ice for 20 min, and cryopreserved until stained. Staining was conducted with polyclonal anti-nitrotyrosine or nonspecific Ab in the presence or absence of excess (10 mM) exogenous free nitrotyrosine (ICN). Cells were washed twice, stained with FITC goat anti-rabbit (Southern Biotech.), and washed an additional three times before analysis by FACScan. The percentage of hapten (nitrotyrosine)-specific staining was calculated from the difference between the mean channel fluorescence of the staining with anti-nitrotyrosine in the absence or presence of 10 mM nitrotyrosine minus any difference in the staining of the nonspecific Ab in the absence or presence of 10 mM nitrotyrosine.
Western blot of NOS isoforms
The 2B4 cells and human T blasts were pelleted, resuspended with NOS buffer (10 mM HEPES, pH 7.5, containing 320 mM sucrose, 100 µM EDTA, 1.5 mM DTT, 10 µg/ml trypsin inhibitor, 10 µg/ml of leupeptin, 2 µg/ml of aprotinin, 1 mg/ml PMSF, and 100 µM tetrahydrobiopterin (27)), snap frozen, and stored at -70°C until analyzed. The samples were sonicated, and the homogenate was analyzed with the use of SDS-PAGE (7% gel). The gels were blotted onto a nitrocellulose membrane (Schleicher & Schuell, Keene, NH) and probed (1:1000) with a polyclonal Ab against nNOS (Transduction Laboratories, Lexington, KY). An anti-rabbit IgG Ab (1:10,000) conjugated to peroxidase (Boehringer Mannheim, Indianapolis, IN) was used as a secondary Ab. An ECL reagent (Pierce, Rockford, IL) and X-OMAT film (Kodak, Rochester, NY) were used to detect the peroxidase conjugate, as described by the manufacturer. Cytosolic fractions of 2B4 cell extracts were adsorbed to ADP-Sepharose to enrich for NOS. The resin was washed with NOS buffer, and the NOS was eluted from the ADP-Sepharose with Laemmli sample buffer. Samples from proteins eluted from the resin as well as nonadsorbed proteins, and those in the wash were analyzed by Western blot, as described above.
Determination of NOS activity in cell extracts
Cells were prepared as described for Western blot analysis in NOS buffer. Aliquots of whole cell lysates (3 mg/ml) were incubated in assay buffer containing 0.2 mM CaCl2, 1 mM NADPH, 30 µM [14C]arginine (330 mCi/mmol), 100 µM tetrahydrobiopterin, 10 µg/ml calmodulin, and 40 mM valine, in a total volume of 200 µl of 40 mM potassium phosphate, pH 7.4. The assay mixture was incubated at 37°C for 10 min, and the amount of [14C]citrulline was determined as previously described (28). Conversion inhibitable by incubation with nine NG-monomethyl-L-arginine (L-NMMA) (2 mM) was considered NOS sp. act.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Cross-linking the TCR of T cell hybridomas or activated,
peripheral T cell blasts with immobilized Ab to the CD3 complex induces
an apoptotic death previously shown to be due to a FasL/Fas-dependent
pathway (2). L-NMMA, at concentrations that did not induce
loss of cell viability, inhibited anti-CD3-induced apoptotic
morphology in a concentration-dependent manner (Fig. 1
, A and B), and a
similar protection was observed with measurements of viability by PI
(data not shown). The control compound D-NMMA, a
stereoisomer that does not inhibit NOS, did not inhibit apoptotic cell
death. Coincubation with other NOS inhibitors,
NG-nitro-L-arginine methyl ester and
7-nitroindazole, exhibited similar concentration-dependent inhibition
of TCR-triggered apoptotic death in both murine and human T cell
models, with 50% inhibition of cell death at 2 and 0.1 mM,
respectively. These inhibitors compete with endogenous arginine in the
normal medium (1 mM), and decreasing the arginine concentration to 0.1
mM led to an increased sensitivity to the effects of L-NMMA
on TCR-triggered death in the human T blasts, as shown by a shift to
the left in the concentration response curve for L-NMMA
inhibition of death (Fig. 1C). Exposure to the steroid
dexamethasone also induces apoptotic cell death of 2B4 cells, and
coincubation with NOS inhibitors did not affect death induced by either
0.1 µM steroid (Fig. 1D), or that induced by 0.01 µM
dexamethasone, which leads to approximately 50% cell death (data not
shown). Thus, the effects of NOS inhibitors do not extend to all models
of apoptotic cell death.
|
If the above results were due to blocking the formation of NO
functioning as a cytotoxic effector, NO would be acting downstream of
Fas cross-linking. To test the role of NO inhibitors on Fas-induced
death, their effect on IgM anti-Fas-induced death of Fas-expressing
Jurkat cells was assessed (Fig. 2A). Coincubation with NOS
inhibitors did not have a significant effect on such Fas-induced cell
death at any concentration of anti-Fas IgM. NOS inhibitors also had
no effect on Fas-dependent killing of labeled Jurkat cells if these
experiments were performed using FasL-bearing effector cells (data not
shown).
|
Since death signaled through Fas was not affected by NOS
inhibitors, effects on FasL expression were investigated through
analysis of functional FasL expression on 2B4 T hybridoma cells.
Surface expression of FasL was induced by incubation of 2B4 cells on
anti-CD3 in the presence or absence of NOS inhibitors, followed by
fixation and assay of their ability to kill 51Cr-labeled,
Fas-bearing Jurkat cells. TCR-triggered expression of functional FasL
in 2B4 cells is inhibited by coincubation with L-NMMA, but
the D-stereoisomer has no effect (Fig. 2
B). If
the data from multiple experiments are expressed in terms of lytic
units (25), L-NMMA exposure leads to a 70% inhibition of
TCR-stimulated functional FasL expression in 2B4 cells (data not
shown).
To confirm the functional assays for FasL expression, direct surface
staining of FasL was performed on human T blasts. Cells incubated on
immobilized anti-CD3 (OKT3) displayed an increased staining with
anti-human FasL Abs, and coincubation with L-NMMA
blocked this up-regulation (Fig. 3).
|
To rule out the effects of NOS inhibitors on early TCR signaling
events as an explanation for their effects on FasL expression, other
TCR signaling-dependent events were measured. Upon incubation on
anti-CD3, 2B4 cells also produce IL-2 in pathway that has been
shown to be distinct from that leading to death (9, 24). Under
conditions that inhibit functional FasL up-regulation,
L-NMMA did not inhibit TCR-triggered IL-2 secretion by 2B4
cells, which was quantitated by bioassay (Fig. 4A). Anti-CD3-induced
up-regulation of surface expression of CD69, an early activation marker
for T cells, was also measured in human T cell blasts. Incubation of
human T cell blasts on anti-CD3, under conditions that induce
apoptotic death, stimulated an increase in the percentage of cells
expressing high levels of CD69, and coincubation with NOS inhibitors,
under conditions that inhibit death, did not affect CD69 expression
(Fig. 4B).
|
Although colorimetric assays for NO production by measurement of
increased nitrite/nitrate formation (29) by 2B4 cells or human T blasts
were negative in the presence or absence of anti-CD3 stimulation
(not shown), further attempts to determine whether NO was being
produced by these cells were done using a more sensitive FACS-based
immunochemical detection assay for intracellular nitrotyrosine in fixed
and permeabilized cells. Previous data have shown that 2B4 cells and
human T blasts generate ROI in response to TCR signals, and the data
further suggest that superoxide anion may be produced (9). If NO and
superoxide anion are both being generated upon TCR signals, then
reaction of the two can form peroxynitrite, which has been shown to
nitrate tyrosines (30). Using a polyclonal Ab to nitrotyrosine (31),
specific staining was detected in both 2B4 cells and human T blasts.
Specific staining was defined as the decrease in fluorescent signal
caused by coincubation with excess (10 mM) soluble nitrotyrosine. A
typical FACS-staining profile is shown (Fig. 5). Exposure to excess nitrotyrosine and
not excess tyrosine (not shown) inhibited, but did not eliminate,
staining by the specific Ab, while it did not alter that of nonspecific
Abs or those specific for other Ags (not shown). Using the mean channel
fluorescence values, nitrotyrosine-specific staining was determined for
each condition, and the percentage of increase in
nitrotyrosine-specific staining induced by TCR signals in 2B4 cells
(Fig. 6A) and human T blasts
(Fig. 6B) was calculated. Stimulation with immobilized
anti-CD3 led to a 30–40% increase in the nitrotyrosine-specific
staining in both cell types, and this was inhibitable by coincubation
with L-NMMA. Incubation with PMA/ionomycin in either cell
type or the combination of pokeweed mitogen and the superantigen
Staphylococcus enterotoxin B in human T blasts led to a
greater increase in nitrotyrosine-specific staining (Fig. 6B). The increases in nitrotyrosine-specific staining
induced by these stronger mitogenic signals were not attenuated as
effectively by coincubation with NOS inhibitors. This parallels the
effects of the NOS inhibitors on apoptotic cell death induced by these
agents, especially in the 2B4 cells (not shown).
|
|
Using a radioactive HPLC assay, L-NMMA-inhibitable
conversion of arginine to citrulline was detected in whole cell lysates
of 2B4 cells. An activity of 7.2 pmol/min/mg protein was determined
(n = 2). Western blot analysis of whole cell lysates or
cytosol preps from 2B4 cells revealed a band that reacts with
polyclonal Abs to nNOS that comigrated with NOS from rat brain cytosol
(Fig. 7). Interestingly, stimulation of
2B4 cells for 6 h on immobilized anti-CD3 leads to an
induction of the immunoreactive band at 160 kDa, which comigrates with
nNOS (Fig. 7). This induction is paralleled by an increase in
L-NMMA-inhibitable NOS activity detected in 2B4 cell
lysates to 18.6 pmol/min/mg protein (n = 2). To further
verify that the immunoreactive band was nNOS, cytosol was adsorbed to
ADP-Sepharose, which binds NADPH-binding proteins. Western blot
analysis showed an enrichment of the 160-kDa band due to binding to the
affinity matrix (data not shown).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Murine T lymphocyte clones have been shown to produce NO upon Ag stimulation through expression of iNOS (20), while other studies have reported detection of eNOS in T cells (22, 23). In the present study, Western blots of 2B4 cell lysates with an Ab to nNOS showed a band at approximately 160 kDa, which is the m.w. of nNOS from rat brain. Interestingly, stimulation through the TCR led to increased expression of nNOS in 2B4 cells. In parallel, low levels of NOS activity were detected in 2B4 cell lysates, and this activity was also induced by TCR cross-linking. Thus, functional nNOS protein is expressed in these T cells. Moreover, NOS activity may be regulated by TCR-stimulated fluxes in intracellular calcium (12), as well as by the induction of NOS.
The NOS in these T cells appears to have a role in activation-induced death, as stereospecific inhibitors to the enzyme L-NMMA, but not D-NMMA, inhibited TCR-triggered cell death in a concentration-dependent manner in both the murine T cell hybridoma and the activated human T cell blasts. A 10-fold decrease in arginine levels of the culture medium led to a shift to the left in the concentration dependence of the inhibitory effects of L-NMMA, further supporting a role for NOS-mediated NO production. Other NOS inhibitors, NG-nitro-L-arginine methyl ester and 7-nitroindazole, which are more selective for nNOS, also inhibited TCR-triggered death in a concentration-dependent manner (data not shown). NOS activity does not appear to be indispensible for cell viability since the NOS inhibitors were not toxic at any of the concentrations examined.
Generation of NO, either from cellular sources or derived from chemical donors, has been shown to induce an apoptotic (32, 33), or even a necrotic cell death (33), while other studies have shown that NO can have a protective effect on apoptosis (34). Exposure to NO donors has been shown to S-nitrosylate and inhibit caspase activation in vitro (35), while cellular expression of NOS has been proposed to inhibit apoptosis of EBV-transformed B lymphocytes (21) and cell death in other systems induced by TNF (35) or Fas (23).
In the current study, NO appeared to be proapoptotic, since NOS
inhibitors block TCR-triggered death and did not sensitize to
Fas-triggered death, as has been observed in recent studies on Fas
killing (23). There was not a direct cytotoxic role for NO in death
stimulated through Fas or steroid, but the stereospecific inhibition of
TCR-stimulated functional FasL up-regulation suggested that NO was
important in the signal transduction leading to FasL expression.
Exposure to NO, through chemical interaction with critical thiols or
coordinated iron (36), has been shown to affect specific
signal-transduction pathways in T lymphocytes such as
p21ras (37), and transcription factors
like nuclear factor-
B (38), AP-1 (39), or CREB (39), which could be
involved in the signals leading to FasL expression. Effects on these
pathways would be consistent with regulation of the transcriptional
activation of FasL mRNA production by TCR-stimulated NO production.
Currently, experiments are aimed at assessing whether NOS inhibitors
block expression of functional FasL induced by TCR cross-linking via
effects at the FasL gene transcription.
TCR stimulation is known to increase the formation of superoxide anion (9), which has been shown in other systems to rapidly react with NO to form peroxynitrite (40), a facile nitrating agent (30, 41). Thus, we aimed to verify that TCR stimulation led to NO generation in situ by immunochemical detection of nitrated tyrosine residues of cellular proteins, which has been shown to be a stable marker for NO generation (41). TCR stimulation increased nitrotyrosine-specific staining, which could be attenuated after treatment with L-NMMA. Not only does the detection of nitrotyrosine prove in situ formation of NO, the formation of peroxynitrite may play a functional role, especially in light of the finding that antioxidants, such as NOS inhibitors, protect from TCR-triggered cell death (9).
Nitrotyrosine formation may be important for FasL expression, although it has been generally shown to have deleterious effects on proteins. For example, levels of nitration correlate with loss of enzymatic function of MnSOD during acute inflammatory response (42), and substrate peptides for tyrosine kinases are not phosphorylated if they are previously altered to have nitrosylated tyrosine residues (43). Thus, increases in nitrotyrosine upon TCR stimulation could affect FasL expression through direct protein modification, or may alter signaling pathways leading to mRNA expression. We are beginning to analyze cells to identify any specifically nitrosylated proteins that may play a role in TCR signaling and/or FasL expression.
In conclusion, the current study demonstrates that mature T lymphocytes have the capacity to form NO, and the production of NO is induced upon antigenic stimulation. This is interesting in light of the observation that mitogenic activation of lymphocytes also leads to selective up-regulation of the amino acid transporter for arginine (44), which increases intracellular concentrations of the amino acid necessary for NO synthesis. From the data, we are proposing a model in which production of both ROI and NO is induced by TCR signaling and that both can affect FasL surface expression, which then engages Fas and stimulates an NO-independent death pathway that has been well characterized (45). One possibility is that NO and ROI are acting through formation of peroxynitrite. The effects of NO and ROI appear to be at least selective for FasL expression, since TCR-dependent IL-2 production and CD69 surface expression were not found to be NO and ROI independent. Thus, the data support the hypothesis that reactive intermediates are important regulators of T cell death, and that pathologic changes in redox status, such as that observed in AIDS or arthritis, may have significant effects on T cell survival and immune responses.
|
Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Mark S. Williams, Department of Immunology, Holland Laboratory, American Red Cross, 15601 Crabbs Branch Way, Rockville, MD 20855. E-mail address:
3 Abbreviations used in this paper: FasL, Fas ligand; eNOS, endothelial nitric oxide synthase; iNOS, inducible nitric oxide synthase; NADPH, nicotinamide-adenine dinucleotide phosphate; NMMA, NG-monomethyl-L-arginine; nNOS, neuronal nitric oxide synthase; NO, nitric oxide; NOS, nitric oxide synthase; PI, propidium iodide; ROI, reactive oxygen intermediates; PCD, programmed cell death; TRITC, tetramethyl rhodamine isothiocyanate.
Received for publication May 13, 1998. Accepted for publication August 14, 1998.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
T lymphocytes. J. Biol. Chem. 272:23211.B
by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270:14214.This article has been cited by other articles:
|
|
 |
|
  J. D. Erusalimsky and S. Moncada Nitric Oxide and Mitochondrial Signaling: From Physiology to Pathophysiology Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2524 - 2531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Haramaki, H. Ikeda, K. Takenaka, A. Katoh, R. Sugano, S.-i. Yamagishi, H. Matsuoka, and T. Imaizumi Fluvastatin Alters Platelet Aggregability in Patients With Hypercholesterolemia: Possible Improvement of Intraplatelet Redox Imbalance via HMG-CoA Reductase Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1471 - 1477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Morita, H. Ikeda, N. Haramaki, H. Eguchi, and T. Imaizumi Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers J. Am. Coll. Cardiol., February 15, 2005; 45(4): 589 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Salmond, R. Williams, T. R. Hirst, and N. A. Williams The B Subunit of Escherichia coli Heat-Labile Enterotoxin Induces Both Caspase-Dependent and -Independent Cell Death Pathways in CD8+ T Cells Infect. Immun., October 1, 2004; 72(10): 5850 - 5857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-B. Voisin, D. Buzoni-Gatel, D. Bout, and F. Velge-Roussel Both Expansion of Regulatory GR1+ CD11b+ Myeloid Cells and Anergy of T Lymphocytes Participate in Hyporesponsiveness of the Lung-Associated Immune System during Acute Toxoplasmosis Infect. Immun., September 1, 2004; 72(9): 5487 - 5492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts Nitric Oxide in Health and Disease of the Respiratory System Physiol Rev, July 1, 2004; 84(3): 731 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sharma, S. A.V. Raghavan, R. Saini, and M. Dikshit Ascorbate-mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocytes: modulatory effect of nitric oxide J. Leukoc. Biol., June 1, 2004; 75(6): 1070 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Nagy, A. Koncz, and A. Perl T Cell Activation-Induced Mitochondrial Hyperpolarization Is Mediated by Ca2+- and Redox-Dependent Production of Nitric Oxide J. Immunol., November 15, 2003; 171(10): 5188 - 5197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-A. Kim, H. K. Avraham, Y.-H. Koh, S. Jiang, I.-W. Park, and S. Avraham HIV-1 Tat-Mediated Apoptosis in Human Brain Microvascular Endothelial Cells J. Immunol., March 1, 2003; 170(5): 2629 - 2637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liversidge, A. Dick, and S. Gordon Nitric Oxide Mediates Apoptosis Through Formation of Peroxynitrite and Fas/Fas-Ligand Interactions in Experimental Autoimmune Uveitis Am. J. Pathol., March 1, 2002; 160(3): 905 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Devadas, L. Zaritskaya, S. G. Rhee, L. Oberley, and M. S. Williams Discrete Generation of Superoxide and Hydrogen Peroxide by T Cell Receptor Stimulation: Selective Regulation of Mitogen-Activated Protein Kinase Activation and Fas Ligand Expression J. Exp. Med., January 7, 2002; 195(1): 59 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kanaya, H. Ikeda, N. Haramaki, T. Murohara, and T. Imaizumi Intraplatelet Tetrahydrobiopterin Plays an Important Role in Regulating Canine Coronary Arterial Thrombosis by Modulating Intraplatelet Nitric Oxide and Superoxide Generation Circulation, November 13, 2001; 104(20): 2478 - 2484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Takajo, H. Ikeda, N. Haramaki, T. Murohara, and T. Imaizumi Augmented oxidative stress of platelets in chronic smokers: Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1320 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Secchiero, A. Gonelli, C. Celeghini, P. Mirandola, L. Guidotti, G. Visani, S. Capitani, and G. Zauli Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies Blood, October 1, 2001; 98(7): 2220 - 2228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Jiménez, J. González-Nicolás, S. Alvarez, M. Fresno, and M. A. Muñoz-Fernández Regulation of Human Immunodeficiency Virus Type 1 Replication in Human T Lymphocytes by Nitric Oxide J. Virol., May 15, 2001; 75(10): 4655 - 4663. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Roozendaal, E. Vellenga, M. A. de Jong, K. F. Traanberg, D. S. Postma, J. G. R. de Monchy, and H. F. Kauffman Resistance of activated human Th2 cells to NO-induced apoptosis is mediated by {{gamma}}-glutamyltranspeptidase Int. Immunol., April 1, 2001; 13(4): 519 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Cherla and R. K. Ganju Stromal Cell-Derived Factor 1{{alpha}}-Induced Chemotaxis in T Cells Is Mediated by Nitric Oxide Signaling Pathways J. Immunol., March 1, 2001; 166(5): 3067 - 3074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Dalton, L. Haynes, C.-Q. Chu, S. L. Swain, and S. Wittmer Interferon {gamma} Eliminates Responding CD4 T Cells during Mycobacterial Infection by Inducing Apoptosis of Activated CD4 T Cells J. Exp. Med., July 3, 2000; 192(1): 117 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Angulo, F. G. de las Heras, J. F. Garcia-Bustos, D. Gargallo, M. A. Munoz-Fernandez, and M. Fresno Nitric oxide-producing CD11b+Ly-6G(Gr-1)+CD31(ER-MP12)+ cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice Blood, January 1, 2000; 95(1): 212 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Allione, P. Bernabei, M. Bosticardo, S. Ariotti, G. Forni, and F. Novelli Nitric Oxide Suppresses Human T Lymphocyte Proliferation Through IFN-{gamma}-Dependent and IFN-{gamma}-Independent Induction of Apoptosis J. Immunol., October 15, 1999; 163(8): 4182 - 4191. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
